Bullish flow in Hims and Hers Health (HIMS), with shares up $2.59, or 9.2%, near $30.74. Options volume running well above average with 243k contracts traded and calls leading puts for a put/call ratio of 0.33, compared to a typical level near 0.37. Implied volatility (IV30) is higher by 5.8 points near 110.27,in the top quartile of the past year, suggesting an expected daily move of $2.14. Put-call skew flattened, suggesting a modestly bullish tone.Looking ahead: Hims and Hers Health (HIMS) will report earnings after the close on None.Option markets are pricing in a 50% probability of a move greater than 0.0% or $0.00.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HIMS:
- Now Is the Time to Buy Hims & Hers Stock (HIMS), Says JPMorgan Chase
- Intel upgraded, DraftKings downgraded: Wall Street’s top analyst calls
- Hims & Hers price target raised to $32 from $30 at BofA
- Hims & Hers initiated with an Overweight at JPMorgan
- Eli Lilly (LLY) Expands Partnership with Hims & Hers
